Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24weeks of treatment

Author:

Werner, C. R.; Franz, C.; Egetemeyr, D. P.; Janke-Maier, P.; Malek, N. P.; Lauer, U. M.; Berg, C. P.

Tübinger Autor(en):

Published in:

Journal of Viral Hepatitis (2014), Bd. 21, H. 5, S. 333-340

Verlagsangabe:

Wiley - Blackwell

Language:

English

Full text:

ISSN:

1352-0504

DDC Classifikation:

610 - Medicine and health
570 - Life sciences; biology

Dokumentart:

Article

This item appears in the following Collection(s)